These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6395800)

  • 21. Translation error clusters induced by aminoglycoside antibiotics.
    Wohlgemuth I; Garofalo R; Samatova E; Günenç AN; Lenz C; Urlaub H; Rodnina MV
    Nat Commun; 2021 Mar; 12(1):1830. PubMed ID: 33758186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of ribosomes of kasugamycin-dependent mutants of Escherichia coli.
    Dabbs ER; Poldermans B; Bakker H; van Knippenberg PH
    FEBS Lett; 1980 Aug; 117(1):164-6. PubMed ID: 6997074
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of action of aminoglycoside antibiotics. Binding studies of tobramycin and its 6'-N-acetyl derivative to the bacterial ribosome and its subunits.
    Le Goffic F; Capmau ML; Tangy F; Baillarge M
    Eur J Biochem; 1979 Dec; 102(1):73-81. PubMed ID: 391568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B.
    Sato M; Mori Y
    J Antibiot (Tokyo); 1979 Apr; 32(4):371-8. PubMed ID: 468724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamine stimulation of ribosomal synthesis and activity in a polyamine-dependent mutant of Escherichia coli.
    Kashiwagi K; Sakai Y; Igarashi K
    Arch Biochem Biophys; 1989 Jan; 268(1):379-87. PubMed ID: 2643387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic.
    Tanaka N; Matsunaga K; Hirata A; Matsuhisa Y; Nishimura T
    Antimicrob Agents Chemother; 1983 Nov; 24(5):797-802. PubMed ID: 6362557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fortimicins C, D and KE, new aminoglycoside antibiotics.
    Sugimoto M; Ishii S; Okachi R; Nara T
    J Antibiot (Tokyo); 1979 Sep; 32(9):868-73. PubMed ID: 511777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basis for prokaryotic specificity of action of aminoglycoside antibiotics.
    Recht MI; Douthwaite S; Puglisi JD
    EMBO J; 1999 Jun; 18(11):3133-8. PubMed ID: 10357824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyamines and antibiotic effects on translation.
    Goldemberg SH; Algranati ID
    Med Biol; 1981 Dec; 59(5-6):360-7. PubMed ID: 7040833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside resistance among blood culture isolates.
    Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of protein synthesis by polypeptide antibiotics.. II. In vitro protein synthesis.
    Ennis HL
    J Bacteriol; 1965 Oct; 90(4):1109-19. PubMed ID: 5321398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Have deoxystreptamine aminoglycoside antibiotics the same binding site on bacterial ribosomes?
    Le Goffic F; Capmau ML; Tangy F; Caminade E
    J Antibiot (Tokyo); 1980 Aug; 33(8):895-9. PubMed ID: 7000739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae.
    Levy J; Burns JL; Mendelman PM; Wong K; Mack K; Smith AL
    Antimicrob Agents Chemother; 1986 Mar; 29(3):474-81. PubMed ID: 3487286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New features of the ribosome and ribosomal inhibitors: non-enzymatic recycling, misreading and back-translocation.
    Szaflarski W; Vesper O; Teraoka Y; Plitta B; Wilson DN; Nierhaus KH
    J Mol Biol; 2008 Jun; 380(1):193-205. PubMed ID: 18508080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro cross-resistance of kanamycin-resistant mutants of E. coli to other aminoglycoside antibiotics.
    Choi EC; Nishimura T; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Dec; 33(12):1527-31. PubMed ID: 7019176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.
    Jones RN; Thornsberry C; Barry AL; Packer RR; Baker CN; Badal RE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):773-9. PubMed ID: 7447431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures.
    Pfister P; Hobbie S; Vicens Q; Böttger EC; Westhof E
    Chembiochem; 2003 Oct; 4(10):1078-88. PubMed ID: 14523926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical modification of fortimicins. III. preparation of N-substituted fortimicin A derivatives.
    Mochida K; Sato M; Yoshiie S; Mori Y; Shirahata K; Kitaura K
    J Antibiot (Tokyo); 1981 May; 34(5):522-9. PubMed ID: 7275834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cations, polyamines and other aminoglycosides on gentamicin C2. Binding to ribosomes from sensitive and resistant Escherichia coli strains.
    Moukaddem M; Tangy F; Capmau ML; Le Goffic F
    J Antibiot (Tokyo); 1986 Jan; 39(1):136-40. PubMed ID: 3512503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.